by Lei Li, Ranran Li, Zhixiong Wu, Xianghong Yang, Mingyan
Zhao, Jiao Liu and Dechang Chen
Annals of Intensive Care volume 10,
Article number: 45 (2020)
Abstract
Since the 2019 novel coronavirus disease (COVID-19) outbreak
originated from Wuhan, Hubei Province, China, at the end of 2019, it has become
a clinical threat to the general population worldwide. Among people infected
with the novel coronavirus (2019-nCoV), the intensive management of the
critically ill patients in intensive care unit (ICU) needs substantial medical
resource. In the present article, we have summarized the promising drugs,
adjunctive agents, respiratory supportive strategies, as well as circulation
management, multiple organ function monitoring and appropriate nutritional
strategies for the treatment of COVID-19 in the ICU based on the previous
experience of treating other viral infections and influenza. These treatments
are referable before the vaccine and specific drugs are available for COVID-19.
No comments:
Post a Comment